SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-19-066346
Filing Date
2019-11-22
Accepted
2019-11-21 20:05:45
Documents
1
Group Members
DR. ANAND MEHRADR. JAMES I. HEALYDR. MICHAEL F. POWELLSOFINNOVA MANAGEMENT IX, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A tm1923694d1_sc13da.htm SC 13D/A 104194
  Complete submission text file 0001104659-19-066346.txt   105831
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners IX, L.P. (Filed by) CIK: 0001612133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Subject) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91004 | Film No.: 191238514
SIC: 2834 Pharmaceutical Preparations